WO2001021148B1 - No-liberating topically applicable composition as biological agent, production and utilization thereof as dermatological and/or cosmetic product - Google Patents
No-liberating topically applicable composition as biological agent, production and utilization thereof as dermatological and/or cosmetic productInfo
- Publication number
- WO2001021148B1 WO2001021148B1 PCT/EP2000/008067 EP0008067W WO0121148B1 WO 2001021148 B1 WO2001021148 B1 WO 2001021148B1 EP 0008067 W EP0008067 W EP 0008067W WO 0121148 B1 WO0121148 B1 WO 0121148B1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- releasing compound
- composition
- effect
- application
- derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Toxicology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00958469A EP1216019A1 (en) | 1999-09-22 | 2000-08-18 | No-liberating topically applicable composition as biological agent, production and utilization thereof as dermatological and/or cosmetic product |
AU69972/00A AU6997200A (en) | 1999-09-22 | 2000-08-18 | No-liberating topically applicable composition as biological agent, production and utilization thereof as dermatological and/or cosmetic product |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19945484.1 | 1999-09-22 | ||
DE19945484A DE19945484A1 (en) | 1999-09-22 | 1999-09-22 | NO-releasing topically applicable composition |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001021148A1 WO2001021148A1 (en) | 2001-03-29 |
WO2001021148B1 true WO2001021148B1 (en) | 2002-06-06 |
Family
ID=7922947
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2000/008067 WO2001021148A1 (en) | 1999-09-22 | 2000-08-18 | No-liberating topically applicable composition as biological agent, production and utilization thereof as dermatological and/or cosmetic product |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1216019A1 (en) |
AU (1) | AU6997200A (en) |
DE (1) | DE19945484A1 (en) |
WO (1) | WO2001021148A1 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2856591B1 (en) * | 2003-06-27 | 2005-10-14 | Oreal | COSMETIC COMPOSITION BASED ON NITROSONIUM SALT (S) FOR THE PERMANENT DEFORMATION OF KERATIN FIBERS. |
FR2856592B1 (en) * | 2003-06-27 | 2008-04-25 | Oreal | A COSMETIC COMPOSITION BASED ON A RADICAL THIYL DRYER (S) FOR THE PERMANENT DEFORMATION OF KERATIN FIBERS |
MXPA05014212A (en) | 2003-07-03 | 2006-08-11 | Univ St Andrews | Zeolites for delivery of nitric oxide. |
GB0821345D0 (en) | 2008-11-21 | 2008-12-31 | P Q Silicas Uk Ltd | Composition and dressing with nitric oxide |
ES2958410T3 (en) | 2009-08-21 | 2024-02-08 | Novan Inc | Topical gels |
WO2013006608A1 (en) | 2011-07-05 | 2013-01-10 | Novan, Inc. | Topical compositions |
EP2833721B1 (en) | 2012-03-14 | 2021-02-17 | Novan Inc. | Nitric oxide releasing pharmaceutical compositions |
US9855211B2 (en) | 2013-02-28 | 2018-01-02 | Novan, Inc. | Topical compositions and methods of using the same |
WO2015021382A2 (en) | 2013-08-08 | 2015-02-12 | Novan, Inc. | Topical compositions and methods of using the same |
US10206947B2 (en) | 2013-08-08 | 2019-02-19 | Novan, Inc. | Topical compositions and methods of using the same |
EP3423100A4 (en) | 2016-03-02 | 2019-10-16 | Novan, Inc. | Compositions for treating inflammation and methods of treating the same |
JP6899845B2 (en) | 2016-04-13 | 2021-07-07 | ノヴァン,インコーポレイテッド | Compositions, systems, kits and methods for treating infectious diseases |
CN112165935A (en) | 2018-03-01 | 2021-01-01 | 诺万公司 | Nitric oxide-releasing suppository and method of use |
CN115089606B (en) * | 2022-06-30 | 2023-09-26 | 安徽医科大学 | Zinc/cerium composite nano material, preparation method thereof and application thereof in psoriasis treatment |
CN117442598B (en) * | 2023-12-25 | 2024-03-12 | 天津嘉氏堂科技有限公司 | Application of nitrate compound in preparation of sensitive muscle epidermis barrier improving product |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3969793A (en) * | 1992-04-13 | 1993-11-18 | United States Of America, Represented By The Secretary, Department Of Health And Human Services, The | Use of nitric oxide/nucleophile complexes for the treatment of cancer |
US5814666A (en) * | 1992-04-13 | 1998-09-29 | The United States As Represented By The Department Of Health And Human Services | Encapsulated and non-encapsulated nitric oxide generators used as antimicrobial agents |
DE4305881C1 (en) * | 1993-02-26 | 1994-03-03 | Lohmann Therapie Syst Lts | Transdermal therapeutic system for topical and systemic application of active agents - includes cpd(s) from which nitrogen oxide is released by human or animal metabolism or cpds which release nitrogen oxide in organism |
ES2292402T3 (en) * | 1994-05-27 | 2008-03-16 | Strakan International Limited | COMPOSITION OF NITRIC OXIDE DONATOR AND METHOD FOR TREATMENT OF ANAL AFFECTIONS |
DE4420523A1 (en) * | 1994-06-13 | 1995-12-14 | Cassella Ag | Treating and preventing SIRS, e.g. in shock, arthritis or peritonitis |
US5519020A (en) * | 1994-10-28 | 1996-05-21 | The University Of Akron | Polymeric wound healing accelerators |
FR2740339B1 (en) * | 1995-10-26 | 1997-12-05 | Oreal | USE OF AT LEAST ONE NO-SYNTHASE INHIBITOR IN THE TREATMENT OF SENSITIVE SKIN |
US5770645A (en) * | 1996-08-02 | 1998-06-23 | Duke University Medical Center | Polymers for delivering nitric oxide in vivo |
US6103275A (en) * | 1998-06-10 | 2000-08-15 | Nitric Oxide Solutions | Systems and methods for topical treatment with nitric oxide |
-
1999
- 1999-09-22 DE DE19945484A patent/DE19945484A1/en not_active Ceased
-
2000
- 2000-08-18 EP EP00958469A patent/EP1216019A1/en not_active Withdrawn
- 2000-08-18 AU AU69972/00A patent/AU6997200A/en not_active Abandoned
- 2000-08-18 WO PCT/EP2000/008067 patent/WO2001021148A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU6997200A (en) | 2001-04-24 |
DE19945484A1 (en) | 2001-04-05 |
WO2001021148A1 (en) | 2001-03-29 |
EP1216019A1 (en) | 2002-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1567143B1 (en) | Anthranilic acid amides and the derivatives thereof as cosmetic and pharmaceutical agents | |
DE60032543T2 (en) | Topically administrable zinc compositions | |
WO2001021148B1 (en) | No-liberating topically applicable composition as biological agent, production and utilization thereof as dermatological and/or cosmetic product | |
DE4420625C1 (en) | Active substance combination with a content of glycerylalkyl ethers and cosmetic and dermatological preparations containing such active substance combinations | |
WO1994025069A1 (en) | Transdermal active-substance preparation | |
EP3082752B1 (en) | Use of alkylamidothiazoles in cosmetic or dermatological preparations for the prophylaxis or treatment of sensitive skin | |
JP2019501934A (en) | Water-in-oil emulsion | |
DE4341000A1 (en) | Use of L-arginine, L-ornithine or L-citrulline and topical preparations with these substances | |
DE69027220T2 (en) | COMPOSITION AND METHOD FOR TREATING PAINFUL INFLAMMABLE OR ALLERGIC DISEASES | |
DE19531893A1 (en) | Itching, cosmetic and / or pharmaceutical compositions | |
EP1641459A1 (en) | Use of osmolytes obtained from extremophilic bacteria for producing medicaments for the external treatment of neurodermatitis | |
EP0486632B1 (en) | Anti-actinic agent | |
DE60316724T2 (en) | PHARMACEUTICAL COMPOSITION CONTAINING CALCITRIOL AND CLOBETASOL PROPIONATE | |
DE4433666A1 (en) | An agent for the treatment or care of irritated or inflamed skin comprising an extract of dried or fresh ribwort plantain (Plantago lanceolata L.) in a base which allows application on the skin as a stick, roller or cream | |
EP2560666B1 (en) | Agent combinationen of magnolia bark extract and surfactace active agents (polyglaceryl(3)-methylglucosedistearate) | |
US20070141167A1 (en) | Use of Benzyl Nicotinate for Pain Relief | |
DE10110418A1 (en) | Melatonin Vitamin A supplements | |
DE202007004981U1 (en) | Composition, in particular for the topical treatment of skin diseases | |
EP2120953B1 (en) | Preparations for the topical treatment of skin diseases | |
DE2720420A1 (en) | COMBINATION OF ACTIVE INGREDIENTS AGAINST SUNNYTHEM AND MEDICINAL PRODUCT CONTAINING THIS | |
AT408837B (en) | USE OF CAROVERIN AND / OR CAROVERIN. HYDROCHLORIDE FOR THE PRODUCTION OF COMPOSITIONS THAT WORK AS AN ANTIOXIDANTS AND / OR OF NEUROREGENERATIVE COMPOSITIONS | |
EP0620000A3 (en) | Cosmetic or pharmaceutical use of N-acylalcanolamines | |
DE102004039983A1 (en) | Pharmaceutical and/or cosmetic composition, useful to treat hair loss (e.g. hormone-induced hair loss) and skin diseases (e.g. acne), comprises fenugreek seeds and additionally flax seeds | |
EP0606590A1 (en) | Pharmaceutical or cosmetic composition containing N-acylalcanolamines and N-acylphospho- or lysophospholipids | |
DE19721580A1 (en) | Use of 1-ar (alk) yl-imidazolin-2-one for the treatment of anxiety and tension |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2000958469 Country of ref document: EP |
|
AK | Designated states |
Kind code of ref document: B1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: B1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWP | Wipo information: published in national office |
Ref document number: 2000958469 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000958469 Country of ref document: EP |
|
NENP | Non-entry into the national phase in: |
Ref country code: JP |